Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Liminal BioSciences Inc. LMNL

Liminal BioSciences is a biopharmaceutical company focused on the discovery and development of novel, small molecule drug candidates for the treatment of patients suffering from fibrotic or inflammatory diseases that have a high unmet medical need. Liminal BioSciences operates on an integrated basis from our talent hubs in Laval, Quebec, Canada, and Cambridge, UK. Our common shares are listed for trading on the Nasdaq Global Market.


NDAQ:LMNL - Post by User

Bullboard Posts
Comment by CCAbbott888on Jun 16, 2019 6:20pm
167 Views
Post# 29830624

RE:RE:These slimes have taken great care to drive the sp down

RE:RE:These slimes have taken great care to drive the sp downstockbuphoon

On SEDI, there were 3 transactions (on June 4), filed on June 10, under Simon Best.

The first two were to do with Grant of option (nature of transaction, code 50):

+15,846,200 @0.036
+1,622,620 @0.036
Both these options have the same expiry date of 2019-06-04

The third one had code 97 (other)
-1,622,620 @0.300
This one has a different expiry date of 2019-01-24

I believe that this third one was the one in question.

According to SEDI Nature of Transaction Codes document here (please click)

10 Acquisition or disposition in the public market
11 Acquisition or disposition carried out privately
 
97 Other
Therefore, it's doubtful, imo, this 1.6M option were sold at 30 cents either in the public market or privately.  

It looks more like that these 1.6M options that has a higher excercise price (0.30) were 'transac' into 15,846,200 options with a lower excersise price (0.036), as they apprear to have the exactly the same 'Closing balance or value of underlying security' of 17,782,204.

Hope that this is clear. CC


Insider name: BEST, SIMON GEOFFREY  
Legend: O - Original transaction, A - First amendment to transaction, A' - Second amendment to transaction, AP - Amendment to paper filing, etc.  
  Insider's Relationship to Issuer: 1 - Issuer, 2 - Subsidiary of Issuer, 3 - 10% Security Holder of Issuer, 4 - Director of Issuer, 5 - Senior Officer of Issuer, 6 - Director or Senior Officer of 10% Security Holder, 7 - Director or Senior Officer of Insider or Subsidiary of Issuer (other than in 4,5,6), 8 - Deemed Insider - 6 Months before becoming Insider.  
Warning: The closing balance of the " equivalent number or value of underlying securities" reflects the" total number or value of underlying securities" to which the derivative contracts held by the insider relate. This disclosure does not mean and should not be taken to indicate that the underlying securities have, in fact, been acquired or disposed of by the insider.  
   
Do you want to view transactions with remarks?  
   
Transaction ID Date of transaction
YYYY-MM-DD
Date of filing
YYYY-MM-DD
Ownership type (and registered holder, if applicable) Nature of transaction Number or value acquired or disposed of Unit price or exercise price Closing balance Insider's calculated balance Conversion
or exercise
price
Date of expiry or maturity
YYYY-MM-DD
Underlying security designation Equivalent number or value of underlying securities acquired or disposed of Closing balance of equivalent number or value of underlying securities  
Issuer name: Prometic Life Sciences Inc.  
Insider's Relationship to Issuer: 4 - Director of Issuer  
Ceased to be Insider: Not applicable  
Security designation: Options (Common Shares)  
        3379878 2019-06-04 2019-06-07 Direct Ownership :  50 - Grant of options +15,846,200 0.0360   17,782,204       2029-06-04 Common Shares +15,846,200 17,782,204  
   
        3379883 2019-06-04 2019-06-07 Direct Ownership :  50 - Grant of options +1,622,620 0.0360   19,404,824       2029-06-04 Common Shares +1,622,620 19,404,824  
   
        3380489 2019-06-04 2019-06-10 Direct Ownership :  97 - Other -1,622,620 0.3000   17,782,204       2029-01-24 Common Shares -1,622,620 17,782,204  

 

Bullboard Posts